Your Health, We Care
Release date: 2025-12-31 14:12:40 Article From: Lucius Laos Recommended: 104
Ivosidenib is also indicated for the treatment of previously treated cholangiocarcinoma (biliary tract cancer) that has spread or is unresectable via surgery.
1. Drugs used to treat cancer are highly potent and may cause numerous adverse reactions. Before taking this medication, ensure that you understand all its potential risks and benefits. Close collaboration with your doctor during treatment is of great importance.
2. Take this medication strictly as prescribed by your doctor. Do not take a dose higher than prescribed, do not administer it more frequently, and do not prolong the duration of administration.
3. A Medication Guide is provided with this drug. Read it carefully and follow the instructions contained therein. Consult your doctor if you have any questions.
4. This medication may be taken with or without food. However, do not take it with high-fat meals.
5. Swallow the tablets whole. Do not crush, split, or chew the tablets.
6. Drink plenty of water to help prevent other adverse reactions.
Given that this is a novel agent for cancer treatment, the current understanding of its potential rare and long-term adverse reactions remains limited. If you notice any unusual, persistent, or concerning changes in your physical condition or subjective feelings during or after treatment—whether or not these symptoms are listed in the known adverse reaction profile—please promptly inform your doctor. Your feedback is of great significance for further clarifying the safety profile of this drug.
Anticancer drugs may interact with other medications, herbal products, as well as certain foods and beverages. It is not possible to list all potential interactions. For example, grapefruit or grapefruit juice may increase the adverse reactions of some drugs.
Please inform your healthcare team of all medications you are taking, including vitamins, herbal supplements, and over-the-counter drugs. Meanwhile, please notify them of any other medical conditions you may have or allergies you suffer from.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：2242025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4512024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：2302025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：2452025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：2232025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2532025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：2342025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2142025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
